Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Neogenix Oncology Logo
Neogenix Oncology (closed)
Neogenix Oncology develops novel therapeutic and diagnostic products for the treatment of cancer patients.
Closed Founded
obfuscation
PrivateVenture - Series Unknown Great Neck, New York, United States11-50 www.neogenixoncology.com
Biotechnology
Health Care
Medical
Oncology

Neogenix Oncology is permanently closed. If you feel this is an error, let us know.

Overview

Neogenix Oncology
Total Funding
obfuscation
Heat Score
5

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score
pts
in past quarter
Heat Score 5
-11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Neogenix Oncology

Neogenix Oncology develops novel therapeutic and diagnostic products for the treatment of cancer patients.
Closed Founded
obfuscation
PrivateVenture - Series Unknown Great Neck, New York, United States11-50 www.neogenixoncology.com
Biotechnology
Health Care
Medical
Oncology

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Neogenix Oncology, Inc.
Operating Status Closed
Company Type For Profit
Founders  Myron Arlen
About the Company

Neogenix Oncology is a clinical stage bio-therapeutics company that focuses on developing novel therapeutic and diagnostic products for the treatment of pancreatic, colon, lung, prostate, and various other cancers. Its primary product, NEO-101, is a novel Phase II monoclonal antibody for colorectal and pancreatic cancer indications.

Neogenix

Oncology’s product pipeline also includes NEO-201 and NEO-301, which are preclinical monoclonal antibodies for the treatment of pancreatic and colorectal cancers. The company also has a research collaboration agreement with San Raffaele-Pisana to study the expression of tumor-specific biomarkers using NEO-101, NEO-201, and NEO-301 therapeutic programs.

Headquartered in Great Neck, New York, Neogenix Oncology was founded in 2003.

Phone Number 516-482-1200
Contact Email info@neogenix.us
Predictions & Insights

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Neogenix Oncology Logo
Venture Round - Neogenix Oncology
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Neogenix Oncology Logo
Venture Round - Neogenix Oncology
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Neogenix Oncology Logo
Venture Round - Neogenix Oncology
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Neogenix Oncology Logo
Venture Round - Neogenix Oncology
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Neogenix Oncology Logo
Venture Round - Neogenix Oncology
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Neogenix Oncology Logo
Venture Round - Neogenix Oncology
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Neogenix Oncology Logo
Venture Round - Neogenix Oncology
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Neogenix Oncology Logo
Venture Round - Neogenix Oncology
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Neogenix Oncology Logo
Venture Round - Neogenix Oncology
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Neogenix Oncology Logo
Venture Round - Neogenix Oncology
—
obfuscation
— Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2

Employee Profiles

News

News and Press

News•Nov 27, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 3, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Active Website Tech Count

2Neogenix Oncology is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.

Total IP

4The intellectual property of Neogenix Oncology includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Neogenix Oncology's headquarters? Neogenix Oncology is located in Great Neck, New York, United States.When was the last funding round for Neogenix Oncology? Neogenix Oncology closed its last funding round on
obfuscation
from a Venture - Series Unknown round.How much funding has Neogenix Oncology raised to date? Neogenix Oncology has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|